CATX
Perspective Therapeutics Inc.
2.90$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.7% | +0.0% | +78.3% | +353.9% | -8.5% | +0.0% | -9.9% | +0.0% | +68.5% | +248.4% | -21.7% | |
| – | -24.7% | +0.0% | +123.2% | +447.7% | -11.8% | +0.0% | -10.3% | +0.0% | -68.4% | +1,272.9% | -35.8% | |
| – | -55.1% | +0.0% | +300.7% | +565.9% | -12.4% | +0.0% | -62.4% | +0.0% | -56.0% | +566.6% | -50.3% | |
| – | -55.1% | +0.0% | +300.7% | +565.9% | – | – | -21.7% | +0.0% | -78.9% | +2,356.3% | -36.2% | |
| – | +77.1% | +0.0% | -15.0% | +15.8% | -20.1% | +0.0% | -15.2% | +0.0% | -13.8% | -90.1% | +795.7% | |
| – | +21.7% | +0.0% | +3.1% | +47.4% | +42.4% | +0.0% | +0.0% | +0.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | -14.8% | +0.0% | -5.8% | +0.0% | -17.7% | +0.0% | -76.6% | +244.0% | +58,451.2% | -0.7% | -20.0% | |
| – | +70.8% | +0.0% | -7.9% | +9.9% | +5.0% | +0.0% | +9.1% | +0.0% | +558.5% | +122.1% | +18.9% | |
| – | +40.5% | +0.0% | -15.2% | +34.9% | +25.8% | +0.0% | +37.6% | -14.2% | +485.4% | +16.4% | +57.3% | |
| – | – | +0.0% | +3.8% | +2.9% | – | – | +0.0% | – | – | +962.1% | -32.7% | |
| – | -4.2% | +0.0% | -24.5% | +47.8% | +32.3% | +0.0% | +59.5% | +0.0% | +348.3% | +49.7% | +98.3% | |
| – | – | – | – | – | – | – | – | – | – | -3.0% | -3.4% | |
| – | -25.5% | +0.0% | +123.2% | +427.7% | -9.1% | +0.0% | -10.8% | +0.0% | +37.6% | +286.6% | -28.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | +0.0% | -18.8% | +89.1% | -86.3% | +899.6% | -90.0% | +900.2% | -61.4% | +17.3% | +14.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.